Corporation
Life Sciences Ontario (LSO)
- Meetings this Parliament
- 1
- With MPs
- 0
- Since Nov 2021
- 22
- Active registrations
- 1
Most recent reported meeting: Aug 27, 2026.
Lobbying by Life Sciences Ontario (LSO): its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.
← LobbyingRegistrations in effect
In-house (corporation) In effect since Aug 27, 2026
Filed by Jason Field, President & CEO
Lobbyists
- Charlini Nicholapillai · Manager of Public and Government Relations
Institutions they may lobby: Finance Canada (FIN), Global Affairs Canada (GAC), Health Canada (HC), House of Commons, Innovation, Science and Economic Development Canada (ISED), Patented Medicine Prices Review Board (PMPRB), Prime Minister's Office (PMO), Privy Council Office (PCO), Senate of Canada, Treasury Board Of Canada Secretariat (TBS)
What they're lobbying on (6)Hide details
- HERC's Commercialization Strategy and Tariff Policy, engagement regarding ISED's commercialization strategy and federal policies related to tariffs, with respect to their implications for the commercialization, growth, investment and competitiveness of Canada's life sciences sector.
- Engagement with Health Canada officials regarding proposed policies to restrict animal testing in Ontario, including discussions on the scientific and regulatory role of animal testing in research and product development
- Engagement with officials regarding aspects of national pharmacare, including proposals for a Canada Drug Agency and a national formulary
- Guidelines, policies and programs related to regulatory and reporting functions of the Patented Medicine Prices Review Board
- Engagement with federal officials regarding Innovation, Science and Economic Development Canada’s plans for the creation of new biomanufacturing capacity for Canada
- Canada’s Innovation and Skills Plan, led by Innovation, Science and Economic Development Canada, with respect to ensuring that the life sciences sector is a major focus of the government’s post-COVID recovery plan
Registration 948248-368641-9. Look it up in the official Registry
Reported meetings
Spreadsheet-
Reported by Jason Field · In-house (corporation)
- Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
HERC's Commercialization Strategy and Tariff Policy, engagement regarding ISED's commercialization strategy and federal policies related to tariffs, with respect to their implications for the commercialization, growth, investment and competitiveness of Canada's life sciences sector. Read more
-
Reported by Jason Field · In-house (corporation)
- Michelle Boudreau · Executive Director, Health Canada (HC)
Economic DevelopmentHealthIndustryResearch and DevelopmentScience and Technology
-
Reported by Jason Field · In-house (corporation)
- Stephen Ellis · Member of Parliament, House of Commons
Economic DevelopmentHealthIndustryIntellectual PropertyResearch and DevelopmentScience and Technology
-
Reported by Jason Field · In-house (corporation)
- Majid Jowhari · Member of Parliament, House of Commons
Economic DevelopmentHealthIndustryIntellectual PropertyResearch and DevelopmentScience and Technology
-
Reported by Jason Field · In-house (corporation)
- Robert Kitchen · Member of Parlilament, House of Commons
Economic DevelopmentHealthIndustryIntellectual PropertyResearch and Development
-
Reported by Jason Field · In-house (corporation)
- Jeff Waring · Director General, Social Development Policy, Privy Council Office (PCO)
Economic DevelopmentHealthIndustryIntellectual PropertyResearch and DevelopmentScience and Technology
-
Reported by Jason Field · In-house (corporation)
- Hilary Peirce · Senior Policy Advisor, Treasury Board Of Canada Secretariat (TBS)
Economic DevelopmentHealthIndustryIntellectual PropertyResearch and DevelopmentScience and Technology
-
Reported by Jason Field · In-house (corporation)
- Sandenga Yeba · Senior Policy Advisor, Health Canada (HC)
Economic DevelopmentHealthIndustryIntellectual PropertyResearch and DevelopmentScience and Technology
-
Reported by Jason Field · In-house (corporation)
- Yash Nanda · Policy Advisor, Finance Canada (FIN)
Economic DevelopmentHealthIndustryIntellectual PropertyResearch and DevelopmentScience and Technology
-
Reported by Jason Field · In-house (corporation)
- Michelle Boudreau · Executive Director, Health Canada (HC)
- Samir Khan · Director, Health Canada (HC)
Economic DevelopmentHealthIndustryIntellectual PropertyResearch and DevelopmentScience and Technology
-
Reported by Jason Field · In-house (corporation)
- Bianca Hossain · Sr Special Assistant, Innovation, Science and Economic Development Canada (ISED)
Economic DevelopmentHealthIndustryResearch and DevelopmentScience and Technology
-
Reported by Jason Field · In-house (corporation)
- Yash Nanda · Policy Advisor, Finance Canada (FIN)
Economic DevelopmentHealthIndustryResearch and DevelopmentScience and Technology
-
Reported by Jason Field · In-house (corporation)
- Michelle Boudreau · Executive Director, Health Canada (HC)
- Samir Khan · Director, Health Canada (HC)
BudgetEconomic DevelopmentHealthIndustryIntellectual PropertyInternational TradeResearch and DevelopmentScience and TechnologyTaxation and Finance
-
Reported by Jason Field · In-house (corporation)
- Jean-Sebastien Bock · Director of Policy, Health Canada (HC)
- Sandenga Yeba · Senior Policy Advisor, Health Canada (HC)
BudgetEconomic DevelopmentHealthIndustryIntellectual PropertyInternational TradeResearch and DevelopmentScience and TechnologyTaxation and Finance
-
Reported by Jason Field · In-house (corporation)
- Bianca Hossain · Sr Special Assistant, Innovation, Science and Economic Development Canada (ISED)
Economic DevelopmentHealthIndustryResearch and Development
-
Reported by Jason Field · In-house (corporation)
- Hilary Peirce · Senior Policy Advisor, Treasury Board Of Canada Secretariat (TBS)
Economic DevelopmentHealthIndustryResearch and DevelopmentScience and Technology
-
Reported by Jason Field · In-house (corporation)
- Sandenga Yeba · Senior Policy Advisor, Health Canada (HC)
Economic DevelopmentHealthIndustryResearch and DevelopmentScience and Technology
-
Reported by Jason Field · In-house (corporation)
- Tyler Norman · Special Assistant - Regional Affairs and Stakeholder Relations - West and North, Global Affairs Canada (GAC)
- Zachary Nixon · Special Assistant, Global Affairs Canada (GAC)
Economic DevelopmentHealthIndustryResearch and DevelopmentScience and Technology
-
Reported by Jason Field · In-house (corporation)
- Mary-Rose Brown · Senior Policy Advisor, Finance Canada (FIN)
Economic DevelopmentHealthIndustryResearch and DevelopmentScience and Technology
-
Reported by Jason Field · In-house (corporation)
- Ed Fast · Member of Parliament, House of Commons
Economic DevelopmentHealthIndustryResearch and DevelopmentScience and Technology
-
Reported by Jason Field · In-house (corporation)
- Kirsty Duncan · Member of Parliament, House of Commons
Economic DevelopmentHealthIndustryResearch and DevelopmentScience and Technology
-
Reported by Jason Field · In-house (corporation)
- Dylan Marando · Senior Policy Advisor, Prime Minister's Office (PMO)
BudgetEconomic DevelopmentHealthIndustryIntellectual PropertyInternational TradeResearch and DevelopmentScience and TechnologyTaxation and Finance
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.